前沿论文｜CELL INTELLIGENCE

Exploring the potential of HVJ-E for cancer immunotherapy.

PubMed 2026/07/09 发表ImmunotherapyQ3 · IF 2.3（JCR 2025）

Oncolytic Herpes Virus G47∆ Potentiates ADCC-Inducing Molecular Targeted Therapy via Coordinated Activation of Innate and Adaptive Immune Responses.

PubMed 2026/05/01 发表Mol Cancer TherQ1 · IF 6.9（JCR 2025）

Reinvigorating the Cancer-Immunity Cycle With Combined Oncolytic Virus and CAR-T Cell Therapies in Solid Tumors.

PubMed 2026/05/01 发表Pathol IntQ3 · IF 1.9（JCR 2025）

Systemic administration of Photobacterium angustum promotes antitumor immunity and direct tumor lysis in murine models of colorectal cancer.

PubMed 2025/11/19 发表J Immunother CancerQ1 · IF 11.7（JCR 2025）

Oncolytic virus-mediated p53 activation boosts the antitumor immunity of a p53-transduced dendritic cell vaccine.

PubMed 2025/07/19 发表NPJ VaccinesQ1 · IF 7.2（JCR 2025）

Next-Generation CAR-T and TCR-T Cell Therapies for Solid Tumors: Innovations, Challenges, and Global Development Trends.

PubMed 2025/06/11 发表Cancers (Basel)Q2 · IF 4.8（JCR 2025）

Enhancing mesothelin CAR T cell therapy for pancreatic cancer with an oncolytic herpes virus boosting CAR target antigen expression.

PubMed 2025/05/14 发表Cancer Immunol ImmunotherQ1 · IF 5.8（JCR 2025）

Advances in Gene Therapy with Oncolytic Viruses and CAR-T Cells and Therapy-Related Groups.

PubMed 2025/04/10 发表Curr Issues Mol BiolQ2 · IF 4.1（JCR 2025）

Mesenchymal stem cell origin contributes to the antitumor effect of oncolytic virus carriers.

PubMed 2024/10/18 发表Mol Ther OncolQ1 · IF 8.5（JCR 2025）

Mesenchymal stem cells as therapeutic vehicles for glioma.

PubMed 2024/04/23 发表Cancer Gene TherQ1 · IF 6.4（JCR 2025）

前沿论文 16